AR Signaling in Human Malignancies: Prostate Cancer and Beyond
by Emmanuel S. Antonarakis (ed.)
Publisher: MDPI AG 2018
ISBN-13: 9783038427391
Number of pages: 246
Description:
This Issue initially reviews the role of AR in advanced prostate cancer, and then explores the potential importance of AR signaling in other epithelial malignancies. The first few articles focus on the use of novel AR-targeting therapies in castration-resistant prostate cancer and the mechanisms of resistance to novel antiandrogens, and they also outline the interaction between AR and other cellular pathways, including PI3 kinase signaling, transcriptional regulation, angiogenesis, stromal factors, Wnt signaling, and epigenetic regulation in prostate cancer.
Download or read it online for free here:
Download link
(9MB, PDF)
Similar books
Gastrointestinal Stromal Tumourby Raimundas Lunevicius - InTech
The era of therapy for GISTs is being proclaimed as bringing the message of special importance to the pathologist role in multidisciplinary team that are responsible for treating patients with locally advanced or metastatic GIST.
(9857 views)
Long-Term Survivorship Care After Cancer Treatment- National Academies Press
To examine progress in cancer survivorship care, participants highlighted opportunities to improve the planning, management, and delivery of cancer survivorship care. This publication summarizes the presentations and discussions from the workshop.
(5410 views)
Endoplasmic Reticulum and Its Role in Tumor Immunityby Paul Eggleton, et al. - Frontiers Media SA
The endoplasmic reticulum (ER) is an organelle crucial to many cellular functions and processes. ER has a well-established central role in anti-tumor immunity. Perhaps best characterized is the role of the ER in the processing of antigen peptides.
(5628 views)
Genetic Susceptibility to Breast and Ovarian Cancer- American College of Medical Genetics
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer.
(9589 views)